← FDA Drug Approvals (Drugs@FDA)
PREGABALIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FOURRTS LABS · Approved 2026-02-24
Drug application
- FDA Application #
ANDA218529- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PREGABALIN
- Generic name
- PREGABALIN
- Active ingredients
- PREGABALIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- FOURRTS LABS
- Manufacturer
- FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED
- First approval
- 2026-02-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown